Tag Archives: uom

Stentrode™ developed for brain treatments without major surgery

Man smiling at the camera, hands in pockets, in Times Sqaure, New York
Tom Oxley, a researcher on the Stentrode, standing in Times Square smiling at the camera

Australian researchers have developed a tiny device that electrically stimulates the brain and could one day be used to treat conditions such as epilepsy and Parkinson’s disease without invasive surgery.

They have shown for the first time that electrical stimulation can be delivered into the brain from a 4 mm diameter Stentrode™ permanently implanted inside a blood vessel.

This technology opens the door for a range of potential treatments that have traditionally required open brain surgery, including deep brain stimulation for Parkinson’s disease and epilepsy.

Deep brain stimulation requires open brain surgery with an electrode implanted via burr hole surgery, where one or more holes are drilled in the skull so the electrodes can penetrate the brain. The Stentrode™ can place electrodes in the brain via blood vessels through a vein in the neck.

The work builds on previous research that showed the Stentrode™ could be used to record brain signals, with the potential to control an exoskeleton in patients with paralysis. This study now shows the Stentrode™ can also deliver targeted stimulation.

PROOF OF CONCEPT

The proof-of-concept study is published in Nature Biomedical Engineering and involved researchers from The University of Melbourne, Florey Institute of Neuroscience and Mental Health, The Royal Melbourne Hospital, Monash University and the company Synchron Australia.

The researchers implanted a 4 mm diameter Stentrode™ into blood vessels in sheep and achieved localised stimulation of brain tissue, all without open-brain surgery. They implanted devices into blood vessels that were adjacent to motor areas of the brain.

“Stimulation-induced responses of the facial muscles and limbs were observed, and were comparable to those obtained with electrodes implanted following invasive surgery,” the researchers wrote.

“A minimally invasive endovascular surgical approach utilising a stent-electrode array is an encouraging safe and efficacious way to stimulate focal regions of brain.”

UNTIL NOW

Until now, it has never been proven that stimulating the brain from inside a blood vessel can achieve focal brain stimulation using a permanently implanted device. Future studies must now determine the safety of stimulation across a range of intensities.

“While additional data is required to validate chronic safety and efficacy of the Stentrode™, our previous research, and literature on the success of commercially available cranial stents and vascular lead wires supports our hypothesis that a Stentrode™ may be a suitable alternative to invasive neural implants,” the researchers said.

Lead researcher Dr Nick Opie said the work built on previous research that showed the Stentrode™ could listen to the motor cortex of the brain.

“By adding the ability to speak to the brain using electrical stimulation, we have created a two-way digital communication device,” Dr Opie said. “In one application, the Stentrode™ could be used as a tool to record the onset of an epileptic seizure, and provide stimulation to prevent it.”

Co-author Dr Sam John said it was the first time such an implant was able to stimulate the brain without needing to perform open brain surgery. He said this work opened the way to making treatment for drug resistant neurological conditions accessible to a greater number of people.

OFFERS HOPE

“This offers hope of less invasive treatments for the symptoms of conditions such as Parkinson’s disease, epilepsy, depression and obsessive compulsive disorder,” he said.

Earlier research, released in 2016, demonstrated that Stentrodes™ implanted into blood vessels next to the motor cortex could pick up brain signals related to movement. The researchers plan to use the Stentrode™ to close the loop, making two-way communication with the brain possible.

In their upcoming clinical trial, the recording Stentrode™ will receive and interpret neural signals and enable a person with Motor Neurone Disease to control communication software.

Eventually it is hoped this technology will be used to help all people suffering from paralysis to control computers, wheelchairs and exoskeletons.

“From within a blood vessel in the head, the Stentrode™ can pick up brain signals when people think about moving”, Dr Opie said. “These can be converted into commands that enable direct-brain control of computers, vehicles or prosthetic limbs. With stimulation, sensory feedback is possible, and people may be able to feel what they are touching.”

 

This article is sourced from our Proud Precinct Partner, the Royal Melbourne Hospital

Forecasting the cycle of epileptic seizures

New research throws light on the predictability of seizure cycles for people with epilepsy

 

Cycles govern most aspects of our day-to-day life and our biology.

There are environmental cycles, like the 8-hour working day, 5-day working week, monthly mortgage repayments and seasonal weather patterns.

Epilepsy is particularly sensitive to metabolic cycles. Picture: Shutterstock
There are also cycles in our body governed by hormonal and metabolic activities, like body temperature, sleep and appetite. Longer biological rhythms exist too, like the menstrual cycle, breeding and hibernation.

It is not surprising that so many interwoven cycles can affect human disease in complex ways. Epilepsy is particularly sensitive to metabolic cycles with seizures known to be provoked by poor sleep, heat stress, alcohol consumption, exercise, changes in mood and even the weather.

Breakthrough: Medicinal cannabis and severe epilepsy

Hundreds of years ago, neurologists documented their patients’ seizure times and found reliable patterns that, for some people, were repeated daily, weekly and monthly.

The cause of these cycles was not clear and the cause of longer cycles remained particularly mysterious. For some women, seizures appeared to be linked to menstruation; however, monthly cycles were also common in men.

Baffled, several researchers resorted to supernatural explanations like ‘moon madness’.

FORECASTING CYCLES

Understanding seizure cycles, and being able to forecast when they will occur, has profound implications for better treatment of epilepsy.

We have conducted the largest study of seizure cycles in humans and our research, published in the Lancet Neurology, provides conclusive evidence that multi-day cycles exist for most people with epilepsy.

A major finding from our study is the high rate of seizure cycles in the population which means that cycles could potentially be affecting the treatment of most people with epilepsy.

Seizures can be provoked by poor sleep, heat stress, alcohol consumption, exercise, changes in mood and even the weather. Picture: Getty Images
We still do not understand the causes of seizure cycles and it is difficult to replicate early studies of multi-day seizure cycles because reliable, longitudinal data of individuals’ seizure times is not typically collected.

Early studies were conducted in a world where people travelled less or lived in closed epilepsy colonies where it was much easier to obtain complete records of a person’s seizure times over decades.

MORE THAN JUST A ‘BAD WEEK’

Q&A: How algorithms are fighting epilepsy
Read more

Nowadays, people with epilepsy may report having a ‘bad week’ at the start of each month, a cluster of seizures every 10 days, or other cyclic patterns. However, while anecdotal evidence of long-term seizure cycles is abundant, experimental proof is lacking

Our study was based on two of the largest databases of human seizures ever recorded. The first dataset is from 15 people with epilepsy who were implanted with a device to continuously recorded their brain signals for up to three years.

The second dataset is a non-invasive, online record of peoples’ seizure times reported via a mobile app SeizureTracker.com, with data sharing supported by the International Seizure Diary Consortium.

The implant data provided an extremely accurate, objective account of seizure times since seizures were directly verified from brain activity. App data is based on self-reporting so is more subjective, but reflects a large and diverse cohort of over 10,000 people reporting for up to 10 years.

 

THE SEVEN-DAY CYCLE

We measured the strength of cycles from periods of 12 hours to three months. A majority (86 per cent) of people had at least one significant cycle
Circadian or 24-hour cycles were most common at 83 per cent, however 23 per cent of people had a seven-day cycle. A quarter of the participants also had at least one cycle that was longer than three weeks.

Gathering self-reported data on peoples’ seizures via a mobile app meant researchers could capture a large and diverse dataset. Picture: Pexels
The existence of a precise seven-day cycle in over one fifth of the cohort was staggering. These weekly cycles suggest human brain activity is entrained to an artificial seven-day week in addition to our brain’s well-documented synchrony with the 24-hour light cycle.

The weekday that most seizures occurred was unique to the individual and, across the population, no day of the week was ‘worse’ than any other day. Like many researchers before us, we also found that longer cycles were equally common in men and women.

So what are the implications of our findings?

 

TREATMENT IMPLICATIONS

Failing to account for multi-day cycles could lead to inconsistent treatment decisions.

For instance, if medication changes were made at the high point of someone’s cycle there would be a perceived benefit because afterwards seizures would begin to decrease.

After the low point of the cycle however, seizures would begin to increase and the drug would seem to be performing badly. Similarly, tracking seizure cycles during clinical trials is important to properly measure the effectiveness of a new drug.

Perhaps the most exciting aspect of this research is that cycles were measured from self-reported mobile seizure diaries. By developing the right software, we can immediately begin using the information from seizure cycles to improve treatment outcomes.

A SEIZURE FORECASTING APP
The main aim of my research is to develop a seizure forecasting app and this study is an important step towards that goal. At our start-up company, Seer, we have developed Beagle Health Tracker, an app that detects the different cycles that modulate individuals’ seizures and present this information graphically.

The Beagle Health Tracker app helps users plan according to their how likely they are to have a seizure that day.

Users can track where they are in a particular cycle, explore the different associated risk levels and schedule medication to align to their unique rhythms. The next step is to incorporate additional data to build a more nuanced picture of an individual’s seizure likelihood.

One important data source available soon is brain signals recorded from outside the skull. Recently our team, lead by Professor Mark Cook, announced that a trial of Minder, a sub-scalp implant device, will begin in Melbourne as early as next year. Devices like Minder are anticipated to revolutionise seizure forecasting.

However, it is important to begin the data collection process now.

Our investigation has taught us that tracking seizure times can reveal rich patterns that can be used to build better forecasts and make a real difference to how people manage epilepsy.

 

This article is sourced from our Proud Precinct Partner,  the University of Melbourne

 

Download the Beagle Health Tracker app

Study Master of Cancer Science in 2019

Logo for Victorian Comprehensive Cancer Centre

Explore an unprecedented breadth of integrated, advanced cancer knowledge

In 2019 the Victorian Comprehensive Cancer Centre with the University of Melbourne is offering a Master of Cancer Sciences program for the first time.

The two-year, part-time course will be Australia’s first cancer-specific, wholly online program, delivered by world-class experts from the Victorian Comprehensive Cancer Centre (VCCC) and Australia’s leading university. It will equip students with cutting-edge, specialist knowledge from the forefront of the rapidly evolving fields of clinical care and cancer research.

Whether you aspire to provide top quality clinical care or high impact cancer research, our Master of Cancer Sciences program will enable you to connect the latest evidence-based knowledge to practical skills, positioning you to make a strong contribution to a world-class cancer workforce.

 

The VCCC is offering 20 supported places to study in 2019

 

Twenty supported places are being offered in 2019, providing 50% fee reduction for the first year. Apply by 30 November.

Core subjects for Masters:

Foundations of Cancer
Cancer Research
Research Thesis Capstone – Part 1 (Core for Masters)
Research Thesis Capstone – Part 2 (Core for Masters)
Electives:
Cancer in Society
Cancer Therapeutics
Cancer Diagnostics
Supportive Care and Palliative Care
Cancer Prevention and Control
Drug Discovery and Development
Cancer Across the Lifespan
End of Life Issues
Foundations of Leadership
Quantitative Methods for Evaluation
Psychosocial Oncology
Health Behaviour Change
Leadership in Practice

Online course options
Term 1 February 2019
Term 2 April 2019
Term 3 July 2019
Term 4 October 2019

Applications close: 14 January 2019

For further information and to register your interest: online.unimelb.edu.au/cancer-sciences

You can also contact The University of Melbourne student support team at study-online@unimelb.edu.au or +61 3 8344 0149 (Mon–Fri 8.00am–9.00pm, Sat–Sun 10.00am–5.00pm, public holidays 10.00am–5.00pm).

This article is sourced from our proud Precinct Partner, VCCC 

 

Hearing Our Voices – 26 November

Australian Health Research Alliance logo, a colourful map of Australia

Hearing Our Voices: The Importance of Community Engagement and Innovation in Indigenous Health Research

When: Monday 26 November 2018, 8:30am-2:30pm

Where: Ian Potter Auditorium, Kenneth Myer Building/Melbourne Brain Centre (University of Melbourne campus)

It is a pleasure to invite you to the one-day conference: “Hearing Our Voices: The Importance of Community Engagement and Innovation in Indigenous Health Research”. The conference is organised by Prof Sandra Eades and A/Prof Elif Ekinci of the University of Melbourne, with funding from the Australian Health Research Alliance in conjunction with the Melbourne Academic Centre for Health, and will take place on 26 November 2018 at The Melbourne Brain Centre’s Ian Potter Auditorium (Kenneth Myer Building), on the main campus of the University of Melbourne.

​Statement of Purpose: To bring together Indigenous health researchers across the Melbourne Academic Health Centre Network and provide a forum for voices to be heard, achievements to be celebrated and collaborations to form.

​Specific outcomes for the Indigenous health research day will be to continue our mapping of Indigenous health research across the MACH network. We also plan to create a videography and pilot mapping project of the people, voices and experiences of those contributing to Indigenous health research, including researchers and students, both Indigenous and non-Indigenous people with a shared commitment for improving Aboriginal & Torres Strait Islander health outcomes. Our activities will culminate in a map of Indigenous health researchers with embedded videos serving as a unique and powerful resource for the MACH network and the University of Melbourne.

​Organising committee:
Prof Sandra Eades, the University of Melbourne, Associate Dean Indigenous
A/Prof Elif Ekinci, the University of Melbourne and Austin Health
A/Prof Luke Burchill, the University of Melbourne and Royal Melbourne Hospital
Prof Stephanie Brown, the University of Melbourne and Murdoch Children’s Research Institute
Ms Heather Whipps, MACH Project Officer

Deadly Yarn: Five-minute talks by students, health workers and other relevant representatives from the Indigenous health research and service delivery world. ***Please note that we are accepting and encouraging submissions from students (UG, Master’s, MPH, PhD, etc), early career researchers, research assistants, program/project officers, clinicians including Aboriginal health workers / hospital liaison officers, other *** The Deadly Yarn may be presented in an academic research or narrative format.

Senior Research: Traditional academic talks of approximately 15 minutes in length.

​Both Deadly Yarn and Senior Research applicants are invited to submit abstracts on the theme ‘the importance of community engagement and innovation in Indigenous health research’. For this inaugural meeting we are seeking abstracts from across the spectrum of MACH’s Indigenous health research community; from the bench to the bedside to population level research. Indigenous community engagement does not need to be the sole or primary focus of the abstract. Participants should however be able to discuss how engaging with Aboriginal & Torres Strait Islander people and communities has influenced their research. Talks from all health and allied health disciplines are welcome.

 

​Important Information:

Deadly Yarn researchers whose abstracts are accepted and who are based outside of Melbourne may receive a travel bursary of up to $500 in order to attend.
Additionally, Deadly Yarn researchers invited to present will be eligible for awards of $500 each for the following categories: “Deadliest Yarn – Overall”, “Top Student Researcher”, “Top Clinician, Project Officer, or Other Health Worker”

Please click here to register (FREE)